Evidence map›Paper›PMID 29029443›Full record

ArticleOncotarget2017

Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma.

Zhenpeng Peng, Chang Li, Tao Chan, Huasong Cai, Yanji Luo, Zhi Dong, Zi-Ping Li, Shi-Ting Feng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Clinical feasibility of accelerated whole liver water TEuropean radiology experimental · 2026
    Article
  2. Article
  3. Accurate and precise in vivo liver 3D TMagnetic resonance in medicine · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Effects of TMedical physics · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances.Journal of clinical and translational hepatology · 2019
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Zhenpeng PengDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
Chang LiDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
Tao ChanDepartment of Diagnostic Radiology, The University of Hong Kong, Pokfulam, Hong Kong.
Huasong CaiDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
Yanji LuoDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
Zhi DongDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
Zi-Ping LiDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
Shi-Ting FengDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
Sun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the difference of T1 relaxation time on Gd-EOB-DTPA-enhanced MRI in hepatocellular carcinoma (HCC), hepatic focal nodular hyperplasia (FNH) and cavernous hemangioma of liver (CHL), and to quantitatively evaluate the uptake of Gd-EOB-DTPA in these three focal liver lesions (FLLs).

resultsThe T1 MATERIALS AND

methods74 patients diagnosed with focal liver lesions underwent Gd-EOB-DTPA-enhanced MRI including T1 mapping were enrolled, consisting of 51 HCCs, 10 FNHs, and 13 CHLs. T1 relaxation times of these lesions were measured on pre-contrast (T1

conclusionsUptake of Gd-EOB-DTPA is different between in HCC, FNH and CHL. These three lesions can be distinguished using T1 mapping.

Indexed as

discriminant analysisfocal liver lesionGd-EOB-DTPAMRIT1 mapping

Identifiers

PMID29029443
PMCPMC5630343
OpenAlexW2731334040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.